Subba Reddy Palli

This inventor holds 36 USPTO granted patents and 12 published patent applications, plus 12 CIPO patents and 12 EPO patents, primarily in Gene Expression Modulation. Top assignees: Intrexon Corporation, University of Kentucky Research Foundation, Rheogene, Inc.. Active years: 2003-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Subba Reddy Palli. Retrieved from https://idiyas.com/inventor/subba-reddy-palli

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 36 (Patent Applications = 12)

% Patents Active = 25.0

CIPO Patents = 12 (Patent Applications = 1)

EPO Patents = 12 (Patent Applications = 4)

Average Co-Inventor Count = 2.4

ph-index = 16

Forward Citations = 547(Granted Patents)

Location History:

Lansdale, PA (US) (2003 - 2016)
Lexington, KY (US) (2009 - 2023)

Company Filing History:

University of Kentucky Research Foundation

Rohm and Haas Company

patents

Years Active: 2003-2023

Loading Chart...

Areas of Expertise:

Gene Expression

Ecdysone Receptors

RNA Interference

Polylysine

Nuclear Receptor

Chimeric Receptors

Inducible Systems

Nanoparticles

Polypeptides

Modulation Systems

Non-Human Organisms

Whitefly

36 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11793829 - Development of polylysine:epigallocatechin-3-o-gallate and dsRNA polyplexes for control of mosquitoes (2023-10-24),

2. 11571394 - Modified-RNA nanoparticles for induction of RNA interference (2023-02-07),

3. 10190124 - Substitution mutant receptors and their use in a nuclear receptor-based inducible gene expression system (2019-01-29),

4. 10087231 - Substitution mutant receptors and their use in an ecdysone receptor-based inducible gene expression system (2018-10-02),

5. 9493540 - Ecdysone receptor/invertebrate retinoid X receptor-based inducible gene expression system (2016-11-15),

6. 9322026 - Substitution mutant receptors and their use in a nuclear receptor-based inducible gene expression system (2016-04-26),

7. 9249207 - Substitution mutant receptors and their use in an ecdysone receptor-based inducible gene expression system (2016-02-02),

8. 9163256 - Mutant receptors and their use in a nuclear receptor-based inducible gene expression system (2015-10-20),

9. 9063140 - Whitefly ecdysone receptor nucleic acids, polypeptides, and uses thereof (2015-06-23),

10. 9029152 - Substitution mutant receptors and their use in a nuclear receptor-based inducible gene expression system (2015-05-12),

11. 8822754 - Ecdysone receptor-based inducible gene expression system (2014-09-02),

12. 8728808 - Multiple inducible gene regulation system (2014-05-20),

13. 8715959 - Substitution mutant receptors and their use in a nuclear receptor-based inducible gene expression system (2014-05-06),

14. 8691527 - Substitution mutant receptors and their use in a nuclear receptor-based inducible gene expression system (2014-04-08),

15. 8680249 - Leafthopper ecdysone receptor nucleic acids, polypeptides, and uses thereof (2014-03-25),

Title: Subba Reddy Palli: Innovator in RNA Interference Technology

Introduction

Subba Reddy Palli, based in Lansdale, PA, is a prominent inventor known for his contributions to the field of biotechnology. With an impressive portfolio of 36 patents, his groundbreaking work focuses primarily on developing innovative RNA interference (RNAi) technologies.

Latest Patents

Among his notable patents are the following:

1. **Development of polylysine:epigallocatechin-3-o-gallate and dsRNA polyplexes for control of mosquitoes** - This invention introduces a novel polyplex composition aimed at modulating gene expression in insects. The composition includes a crosslinker, a cation, and a molecule designed to initiate RNA interference, enhancing the capability to control gene modulation in insects.

2. **Modified-RNA nanoparticles for induction of RNA interference** - This patent showcases improved RNA interference efficiency, particularly in insects. The use of nanoformulations of double-stranded RNA (dsRNA) limits nuclease degradation and enhances cellular uptake, thereby improving the delivery of dsRNA to achieve effective RNAi.

Career Highlights

Subba Reddy Palli has had a distinguished career, contributing his expertise to organizations such as Intrexon Corporation and the University of Kentucky Research Foundation. His work within these institutions has significantly advanced the understanding and application of RNAi technologies.

Collaborations

Throughout his career, Palli has collaborated with talented individuals like Dean Ervin Cress and Mohan Basavaraju Kumar. These partnerships have facilitated innovative research and development, contributing to the successful outcomes of their joint projects.

Conclusion

Subba Reddy Palli's inventive spirit and dedication to advancing biotechnology through RNA interference demonstrate his status as a leading figure in this field. His ongoing contributions have the potential to revolutionize pest control and genetic research, solidifying his place in the annals of innovation.

Profile summary based on public USPTO records.